Neil Came
0000-0002-4715-3886
3 papers found
Refreshing results…
Validation of a modified pre‐lysis sample preparation technique for flow cytometric minimal residual disease assessment in multiple myeloma, chronic lymphocytic leukemia, and B‐non Hodgkin lymphoma
A synonymous GATA2 variant underlying familial myeloid malignancy with striking intrafamilial phenotypic variability
Undetectable peripheral blood MRD should be the goal of venetoclax in CLL, but attainment plateaus after 24 months
Missing publications? Search for publications with a matching author name.